Cann to defend legal proceedings brought by Rua Biosciences
Filed with ASX · · 1 page · English
Earlier from Cann
- Quarterly activities report and Appendix 4C - December 2023
- Cann Group raises A$2m via Convertible Securities Facility
- Voluntary Suspension
- Quarterly activities report and Appendix 4C - September 2023
- Annual General Meeting presentation
Later from Cann
- Appendix 4D & Half Year Report
- Cann announces FY24 half year results
- Suspension from Quotation
- Funding Update
- Resignation of CEO
Follow Cann into a list and get an email when it puts out news.
Follow Cann